cranioectodermal dysplasia 2
MONDO:0013323
Any cranioectodermal dysplasia in which the cause of the disease is a mutation in the WDR35 gene.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
MONDO disease family
Recruiting studies by city
Trial status
Trial phase
Study start year
Investigated drug interventions
Sensenbrenner syndrome
Sensenbrenner syndrome (OMIM #218330) is a rare (less than 20 cases reported by 2010) ciliopathy first described by Judith A. Sensenbrenner in 1975. It is inherited in an autosomal recessive fashion, and is caused by a loss of function mutation in one of three genes: IFT122, IFT43, and WDR35. It is also known as Sensenbrenner–Dorst–Owens syndrome, Levin syndrome I and cranioectodermal dysplasia (CED)
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.